Similar articles

• Tenofovir disoproxil fumarate exhibits strong antiviral effect in a patient with lamivudine-resistant severe hepatitis B reactivation.

  Van Bömmel F, Schernick A, Hopf U, Berg T. Van Bömmel F, et al. Gastroenterology. 2003 Feb;124(2):586-7. doi: 10.1053/gast.2003.1240586b. Gastroenterology. 2003. PMID: 12557178 No abstract available.
• Failure of lamivudine therapy for chemotherapy-induced reactivation of hepatitis B.

  Cainelli F, Longhi MS, Concia E, Vento S. Cainelli F, et al. Am J Gastroenterol. 2001 May;96(5):1651-2. doi: 10.1111/j.1572-0241.2001.03824.x. Am J Gastroenterol. 2001. PMID: 11374725 No abstract available.
• Drug-resistant viral hepatitis.

  Wright M, Main J, Thomas HC. Wright M, et al. J Infect. 2000 Jul;41(1):1-4. doi: 10.1053/jinf.2000.0658. J Infect. 2000. PMID: 10942634 Review. No abstract available.
• Occurrence and clinical outcome of lamivudine-resistant hepatitis B infection after liver transplantation.

  Seehofer D, Rayes N, Steinmüller T, Müller AR, Settmacher U, Neuhaus R, Radke C, Berg T, Hopf U, Neuhaus P. Seehofer D, et al. Liver Transpl. 2001 Nov;7(11):976-82. doi: 10.1053/jlts.2001.28442. Liver Transpl. 2001. PMID: 11699034
• Clinical experience with lamivudine.

  Leung N. Leung N. Semin Liver Dis. 2002;22 Suppl 1:15-21. doi: 10.1055/s-2002-35696. Semin Liver Dis. 2002. PMID: 12447725 Review.